1. Safety updates to Canadian labelling for Duragesic

   News item 21 January 2013 Pages: 2 - 2

2. UK MHRA warns against Chinese slimming aids

   Media release 21 January 2013 Pages: 2 - 2

3. US Erbitux labelling updated

   News item 21 January 2013 Pages: 2 - 2

4. Campath dosing suspended in phase II trial: cases of severe ITP

   Media release 21 January 2013 Pages: 3 - 3

5. Long-acting insulin detemir limits weight gain in type 2 DM

   Media release 21 January 2013 Pages: 3 - 3

6. Methylnaltrexone: positive results in opiate-induced constipation

   Media release 21 January 2013 Pages: 3 - 3

7. Corticosteroid use in SARS: increased ICU admission, mortality

   Clinical study 21 January 2013 Pages: 4 - 4

8. Levofloxacin prevents febrile episodes in neutropenia, cancer

   News item 21 January 2013 Pages: 4 - 4

9. Adverse cardiovascular effects of NSAIDs

   Meeting report 21 January 2013 Pages: 5 - 6

10. Allopurinol

    Case report 21 January 2013 Pages: 7 - 7

11. Antineoplastics

    Case report 21 January 2013 Pages: 7 - 7

12. Aprotinin

    Case report 21 January 2013 Pages: 7 - 8

13. Azathioprine

    Case report 21 January 2013 Pages: 8 - 8

14. Carboplatin/docetaxel

    Case report 21 January 2013 Pages: 8 - 8

15. Ciclosporin

    Case report 21 January 2013 Pages: 8 - 8

16. Lansoprazole

    Case report 21 January 2013 Pages: 9 - 9

17. Mycophenolate mofetil

    Case report 21 January 2013 Pages: 9 - 9

18. Nicorandil

    Case report 21 January 2013 Pages: 9 - 9

19. Phentermine

    Case report 21 January 2013 Pages: 9 - 10

20. Risedronic acid

    Case report 21 January 2013 Pages: 10 - 10

21. Rocuronium bromide

    Case report 21 January 2013 Pages: 10 - 11